312 results
Page 5 of 16
424B5
meu0aa504yimp1 3ozz
12 Nov 20
Prospectus supplement for primary offering
4:57pm
8-K
EX-99.1
ffzdp3cp
9 Nov 20
Cassava Sciences Reports Third Quarter 2020 Financial Results
8:30am
8-K
EX-99.1
ef86vu afw67uh
14 Sep 20
Regulation FD Disclosure
4:01pm
8-K
EX-99.2
71c9wdj 07n
14 Sep 20
Regulation FD Disclosure
4:01pm
8-K
EX-10.1
xjpzs5 3smh1j
1 Sep 20
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.1
smfpc
12 Aug 20
Cassava Sciences Announces Second Quarter 2020 Financial Results and Mid-year Business Review
8:30am
8-K
EX-99.2
pfdu12zuwn66ihpgfpp
3 Jun 20
Regulation FD Disclosure
5:29pm
8-K
EX-99.1
e83wvfx40xz mhy
15 May 20
Top-line Results from a Phase 2b Study of PTI-125 in Alzheimer’s Disease Does Not Meet Primary Endpoint
8:20am
8-K
EX-99.1
p9bte
6 May 20
Cassava Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
8:16am
424B2
z96fcly
5 May 20
Prospectus for primary offering
4:38pm